Compounds > n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride
Page last updated: 2024-09-03

n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and panamesine

n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with panamesine in 1 studies

Compound Research Comparison

Studies
(n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride)		Trials
(n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride)		Recent Studies (post-2010)
(n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride)		Studies
(panamesine)		Trials
(panamesine)		Recent Studies (post-2010) (panamesine)
980291340

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okuyama, S1

Reviews

1 review(s) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and panamesine

ArticleYear
[Atypical antipsychotic profiles of sigma receptor ligands].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1999, Volume: 114, Issue:1

    Topics: Animals; Anisoles; Antipsychotic Agents; Clinical Trials as Topic; Dopamine; Dopamine D2 Receptor Antagonists; Drug Evaluation, Preclinical; Humans; Ligands; Oxazoles; Piperazines; Piperidines; Propylamines; Pyrrolidines; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Receptors, sigma; Tartrates

1999